Call Options Transactions Made in Q4 2024 in Keros Therapeutics, Inc. (KROS)
This table provides information about the institutional ownership of Keros Therapeutics, Inc. (KROS) during Q4 2024. The information is specifically focused on institutions that hold call options of Keros Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2025
Q4 2024
|
Nantahala Capital Management, LLC
New Canaan, CT |
BUY
|
CALL |
250KNew |
$3.91M - $17.5M
|
250K
$2.65M
|
|
|
Feb 14, 2025
Q4 2024
|
Diadema Partners LP
Morristown, NJ |
BUY
|
CALL |
130KNew |
$2.03M - $9.1M
|
130K
$1.38M
|
|
|
Feb 14, 2025
Q4 2024
|
Hudson Bay Capital Management LP
Greenwich, CT |
BUY
|
CALL |
100KNew |
$1.56M - $7M
|
100K
$1.06M
|
|
|
Feb 14, 2025
Q4 2024
|
Jane Street Group, LLC
New York, NY |
BUY
|
CALL |
52.6K+ 571.74% |
$823K - $3.68M
|
61.8K
$656K
|
|
|
Feb 14, 2025
Q4 2024
|
J. Goldman & CO LP
New York, NY |
BUY
|
CALL |
40KNew |
$626K - $2.8M
|
40K
$424K
|
|
|
Feb 14, 2025
Q4 2024
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
12.5K+ 71.43% |
$196K - $875K
|
30K
$318K
|
|
|
Feb 14, 2025
Q4 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
2.7K+ 23.89% |
$42.2K - $189K
|
14K
$149K
|
|
|
Feb 14, 2025
Q4 2024
|
Persistent Asset Partners LTD
Hong Kong, K3 |
BUY
|
CALL |
354New |
$5.54K - $24.8K
|
354
$3.76K
|
|
|
Feb 14, 2025
Q4 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-4.1K- 16.8% |
$64.1K - $287K
|
20.3K
$215K
|